Navigation Links
Allergic reaction to DTaP vaccine persists in children

It is a must for every child to be vaccinated against diphtheria-tetanus-pertussis. The fifth and last vaccine (DTaP) given to children causes a red splotch to develop on the area.

This reaction can last a few days and the problem is that// neither of two common drugs--ibuprofen (Advil) and acetaminophen (Tylenol)--help prevent this side effect. A Group Health Cooperative study appearing in the March issue of Paediatrics features this report.

Lisa A. Jackson, MD, MPH, a senior investigator at Group Health's Center for Health Studies and the study's lead investigator said, "Often children don't notice they have it. But it can concern parents, leading to medical visits or even needless antibiotic treatment, so we'd like to make it rarer."

372 children from 4 to 6 years old who were due for their fifth DTaP dose after getting 4 doses of this vaccine since age 2 months were observed. Four in 10 children were randomly assigned to receive ibuprofen; 4 in 10, acetaminophen; and 2 in 10, placebo.

The medication was given preventively 3 times: at 2 hours before, and 6 and 12 hours after, the vaccination. About a third of each group had local reactions at least 2 inches wide. The placebo and treatment groups did not differ significantly in their proportions of children whose reactions lasted at least 3 days or whose vaccinated limb swelled by about 1 inch or more.

As an explanation by Jackson, "Acetaminophen is an effective anti-pyretic (fever reducer). But it isn't an anti-inflammatory (inflammation reducer). We certainly thought that ibuprofen, through its anti-inflammatory effect, might make the local reactions less common or severe. We all want to decrease discomfort in children, so we were disappointed not to show a prevention effect for ibuprofen; but on the other hand we got a fairly definitive answer, and that's why we do research."

The acellular vaccine, licensed in 1997, contains only those parts of the dip htheria (whooping cough) bacteria that are critical to providing immunity. The previous version--whole cellular DTP vaccine--contained whole bacteria. The newer acellular shot results in less fever in 2- and 4-month-old babies than did the older whole-cell shot. This is significant because fever can lead to seizures--rare, but serious, adverse events associated with the DTP shot.
'"/>




Related medicine news :

1. Diet Can Influence Allergic Skin Reactions
2. New Treatment For People Allergic To Cats
3. Red Color Causes The Allergic Reaction To Strawberries
4. New Insight Gained For Allergic Reactions
5. Anthroposophical Lifestyle Reduces Risk Of Allergic Disease In Children
6. Number of Allergic Anaphylaxis Episodes Are Far More Than Those Recorded
7. Eye Drug Macugen Shows Allergic Reactions
8. Allergic to Kisses?
9. Preventive Measures Proved Ineffective in Allergic Children
10. New Cooperative Research Center for Allergic Disease
11. Allergic Symptoms on the Rise in Britain
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, ... development and joint health in horses at the immunologic level. , The scientifically-developed ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Eyevensys, a private biotechnology company developing its ... that enables the safe, local, sustained production of therapeutic ... of ophthalmic diseases, announces it has received approval from ... to advance its technology into clinical development. ... The EyeCET platform uses ...
(Date:4/19/2017)... -- The Mobile X-Ray product segment is the most attractive ... forecast period Mobile X-Ray segment is the largest ... devices market, which is estimated to be valued at more ... of 7% over the forecast period. Mobile X-Ray segment is ... 100 Mn in 2017 over 2016. The segment,s revenue in ...
(Date:4/19/2017)... , April 19, 2017 The Global ... Forecast to 2022 report has covered and analysed the potential ... information on market size, shares and growth factors. The report ... challenges and opportunities in the global market. ... Browse 152 Tables and Figures, 6 Major ...
Breaking Medicine Technology: